.
Total number of sequences represented in ASVs. Table S2 .
Relative genera abundances identified for each patient's endometrium. Figure S1 . ASV rarefaction curves of bacterial 16S rRNA gene amplicon sequences.
Figure S2.
Faith index values related to the bacterial 16S rRNA gene amplicon sequences for the endometrial samples. Figure S3 . NMDS plots based on UniFrac and Bray-Curtis matrixes. Table S1 : Total number of sequences represented in ASV per each sample after the contaminants removal. S1-S19 indicate the different subjects. Samples are ordered according to the number of observed sequences. Table S2   Table S2 . Relative genera abundances identified for each patient's endometrium (only genera with abundances higher than 1% are reported). S1-S19 indicate the different subjects.
Figure S1
Figure S1. ASV rarefaction curves of bacterial 16S rRNA gene amplicon sequences for endometrial samples. S1-S19 indicate the different subjects.
Figure S2
Figure S2. Faith index values related to the bacterial 16S rRNA gene amplicon sequences for the endometrial samples. S1-S19 indicate the different subjects. Coloured dots correspond to single V5-V6 amplicon sequencing sample.
6 Figure S3 A B C Figure S3 . NMDS plots based on UniFrac weighted dissimilarity matrix (A), UniFrac unweighted dissimilarity matrix (B) and Bray-Curtis matrix (C). S1-S19 indicate the different subjects. Coloured dots correspond to single V5-V6 amplicon sequencing sample.
